2019
DOI: 10.1038/s41419-019-1548-7
|View full text |Cite
|
Sign up to set email alerts
|

Ginseng metabolite Protopanaxadiol induces Sestrin2 expression and AMPK activation through GCN2 and PERK

Abstract: Ginseng is one of the most commonly used herbs that is believed to have a variety of biological activities, including reducing blood sugar and cholesterol levels, anti-cancer, and anti-diabetes activities. However, little is known about the molecular mechanisms involved. In this study, we showed that protopanaxadiol (PPD), a metabolite of the protopanaxadiol group ginsenosides that are the major pharmacological constituents of ginsengs, significantly altered the expression of genes involved in metabolism, elev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 56 publications
(54 reference statements)
0
13
0
Order By: Relevance
“…The naturally occurring resveratrol inhibits hepatic lipogenesis through Sesn2 induction (Jin et al, 2013), thus keeping fatty liver in check. Nelfinavir/bortezomib (Bruning et al, 2013) and protopanaxadiol (PPD) (Jin et al, 2019) are known to induce Sesn2 through protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)/ cyclic AMP-dependent transcriptional factor (ATF) 4 activation upon ER stress. Albeit the increasing therapeutic potential of allosteric modulation of Sestrin2 is promising, the unexpected side effects should be thoroughly examined by animal studies and human clinical trials.…”
Section: Introduction Of Sestrinsmentioning
confidence: 99%
“…The naturally occurring resveratrol inhibits hepatic lipogenesis through Sesn2 induction (Jin et al, 2013), thus keeping fatty liver in check. Nelfinavir/bortezomib (Bruning et al, 2013) and protopanaxadiol (PPD) (Jin et al, 2019) are known to induce Sesn2 through protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)/ cyclic AMP-dependent transcriptional factor (ATF) 4 activation upon ER stress. Albeit the increasing therapeutic potential of allosteric modulation of Sestrin2 is promising, the unexpected side effects should be thoroughly examined by animal studies and human clinical trials.…”
Section: Introduction Of Sestrinsmentioning
confidence: 99%
“…It is a common phenomenon that PERK and GCN2 kinases simultaneously regulate the same substrate (Hamanaka et al, 2005;Krishnamoorthy et al, 2008;You et al, 2018;Jin et al, 2019). We used PERK or GCN2 inhibitor to treat DEFs and found that both inhibitors can attenuate eIF2α phosphorylation, related to the redundancy or even compensation of the two kinases' functions (Donnelly et al, 2013;You et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of GCN2 reduces LC3 accumulation when arginine is downregulated due to IFN-γ treatment in bovine mammary epithelial cells (BMECs) [ 41 ]. In HCT116 cells, GCN2 functions downstream of protopanaxadiol (PPD) to promote autophagy by upregulating the expression of Sestrin2 [ 42 ]. Interestingly, Sestrin2 interferes with translocation of mTORC1 to lysosomes [ 43 ], thereby inhibiting mTORC1 activity.…”
Section: Sensing Mechanisms Of Amino Acid Regulation Autophagymentioning
confidence: 99%